The Patent Finder

Biomoda, Inc.

Also on record
Records under this name other than patents Biomoda, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to Biomoda, Inc.

PatentTitleStatus Expires Confidence
US 8,877,509System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP)
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,384,764Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Formerly held
Term ended
Term ended Nov 3, 2022 · From the USPTO record
Term endedTerm ended Nov 3, 2022From the USPTO record
US 6,838,248Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Formerly held
Term ended
Term ended Aug 5, 2022 · From the USPTO record
Term endedTerm ended Aug 5, 2022From the USPTO record
US 7,670,799Method for making 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) solution and composition comprising TCPP
Formerly held
Term ended
Term ended Nov 19, 2021 · From the USPTO record
Term endedTerm ended Nov 19, 2021From the USPTO record
US 7,960,138Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Formerly held
Term ended
Ended no later than Nov 19, 2021 · From the USPTO record
Term endedEnded no later than Nov 19, 2021From the USPTO record
US 8,975,038Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Formerly held
Term ended
Ended no later than Nov 19, 2021 · From the USPTO record
Term endedEnded no later than Nov 19, 2021From the USPTO record
US 9,417,2415, 10, 15, 20-tetrakis (carboxyphenyl) porphine (TCPP) and kit for use with detecting cancer
Formerly held
Term ended
Term ended Nov 19, 2021 · From the USPTO record
Term endedTerm ended Nov 19, 2021From the USPTO record
US 8,486,656Method for prognosing response to cancer therapy with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
Formerly held
Lapsed on the fee record
Ended Jul 16, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jul 16, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited